share_log

Earnings Scheduled For March 20, 2023

Benzinga ·  Mar 21, 2023 01:29

Companies Reporting Before The Bell

• Niu Technologies (NASDAQ:NIU) is likely to report earnings for its fourth quarter.

• DouYu Intl Hldgs (NASDAQ:DOYU) is likely to report quarterly earnings at $0.00 per share on revenue of $241.59 million.

• Kanzhun (NASDAQ:BZ) is expected to report earnings for its fourth quarter.

• RVL Pharmaceuticals (NASDAQ:RVLP) is expected to report quarterly loss at $0.16 per share on revenue of $12.60 million.

• LightInTheBox Holding (NYSE:LITB) is projected to report earnings for its fourth quarter.

• PDD Holdings (NASDAQ:PDD) is estimated to report earnings for its fourth quarter.

• Yunji (NASDAQ:YJ) is likely to report earnings for its fourth quarter.

• Abcam (NASDAQ:ABCM) is likely to report earnings for its Fiscal Year 2022.

• Movano (NASDAQ:MOVE) is estimated to report earnings for its fourth quarter.

• Foot Locker (NYSE:FL) is expected to report quarterly earnings at $0.50 per share on revenue of $2.14 billion.

Companies Reporting After The Bell

• Bridger Aerospace Gr (NASDAQ:BAER) is likely to report earnings for its fourth quarter.

• Puyi (NASDAQ:PUYI) is likely to report earnings for its first quarter.

• Ampco-Pittsburgh (NYSE:AP) is expected to report earnings for its fourth quarter.

• Lantern Pharma (NASDAQ:LTRN) is expected to report earnings for its fourth quarter.

• Dragonfly Energy Hldgs (NASDAQ:DFLI) is estimated to report quarterly loss at $0.20 per share on revenue of $23.92 million.

• Sanara MedTech (NASDAQ:SMTI) is likely to report quarterly loss at $0.26 per share on revenue of $14.80 million.

• Exagen (NASDAQ:XGN) is estimated to report quarterly loss at $0.78 per share on revenue of $8.66 million.

• Flotek Industries (NYSE:FTK) is likely to report quarterly loss at $0.07 per share on revenue of $51.30 million.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment